Efficacy of Low-Level Laser Therapy for the Therapeutic Management of Neuropathic Orofacial Pain: A Systematic Review

Aims: To evaluate the efficacy of low-level laser therapy (LLLT) for the therapeutic management of neuropathic orofacial pain. Methods: This systematic review was conducted according to PRISMA guidelines. A comprehensive search of the literature was conducted in the PubMed/MEDLINE, Scopus, and Cochrane Library databases up to March 8, 2018, using terms such as low-level laser therapy, neuropathic pain, orofacial pain, neuralgia, neuropathy, and all the entities described in section 13 of the International Classification of Headache Disorders, third edition. The primary outcome was measurement of pain intensity. Results: A total of 997 studies were obtained with the initial search; 13 (8 randomized controlled trials, 2 prospective studies, and 3 case series) met the inclusion criteria and were analyzed for data extraction. Three provided data for the treatment of trigeminal neuralgia, 1 for occipital neuralgia, and 10 for burning mouth syndrome. All studies showed a reduction in pain intensity (most of them significant). The different studies analyzed LLLT alone and compared to placebo, to another treatment, or to different LLLT application protocols. Conclusion: LLLT seems to be effective as a treatment option for different neuropathic orofacial pain entities such as trigeminal neuralgia, occipital neuralgia, and burning mouth syndrome as a single or combined treatment. However, more quality studies assessing all outcome measures of chronic pain are needed in the medium and long terms. Furthermore, due to the lack of standardization of the application technique, more well-designed studies are required to confirm the results of this systematic review.

low-level laser therapy; neuropathic pain; orofacial pain; systematic review

1. Haanpää M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152:14–27.

2. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.

3. Benoliel R, Gaul C. Persistent idiopathic facial pain. Cephalalgia 2017;37:680–691.

4. Baad-Hansen L, Benoliel R. Neuropathic orofacial pain: Facts and fiction. Cephalalgia 2017;37:670–679.

5. Benoliel R, Teich S, Eliav E. Painful traumatic trigeminal neuropathy. Oral Maxillofac Surg Clin North Am 2016;28:371–380.

6. Weiss AL, Ehrhardt KP, Tolba R. Atypical facial pain: A comprehensive, evidence-based review. Curr Pain Headache Rep 2017;21:8.

7. Tait RC, Ferguson M, Herndon CM. Chronic orofacial pain: Burning mouth syndrome and other neuropathic disorders. J Pain Manag Med 2017;3(1).

8. McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev 2016;11:CD002779.

9. Alshukry A, Salburgo F, Jaloux L, Lavieille JP, Montava M. Trigeminal neuralgia (TN): A descriptive literature analysis on the diagnosis and management modalities. J Stomatol Oral Maxillofac Surg 2017;118:251–254.

10. Pandeshwar P, Roa MD, Das R, Shastry SP, Kaul R, Srinivasreddy MB. Photobiomodulation in oral medicine: A review. J Investig Clin Dent 2016;7:114–126.

11. Bjordal JM, Couppé C, Chow RT, Tunér J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother 2003;49:107–116.

12. Figueiredo AL, Lins L, Cattony AC, Falcao AF. Laser therapy in the control of oral mucositis: A meta-analysis. Rev Assoc Med Bras (1992) 2013;59:467–474.

13. Jajarm HH, Falaki F, Mahdavi O. A comparative pilot study of low intensity laser versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus. Photomed Laser Surg 2011;29:421–425.

14. de Paula Eduardo C, Aranha AC, Simões A, et al. Laser treatment of recurrent herpes labialis: A literature review. Lasers Med Sci 2014;29:1517–1529.

15. De Souza TO, Martins MA, Bussadori SK, et al. Clinical evalua-tion of low-level laser treatment for recurring aphthous stomatitis. Photomed Laser Surg 2010;28(suppl 2):s85–s88.

16. Pavli´c V. The effects of low-level laser therapy on xerostomia (mouth dryness) [in Serbian]. Med Pregl 2012;65:247–250.

17. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.

18. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1. The Cochrane Collaboration, 2011. http://handbook-5-1.cochrane.org/. Accessed May 1, 2019.

19. Antonic´ R, Brumini M, Vidovic I, Urek MM, Glažar I, Pezelj-Ribaric S. The effects of low level laser therapy on the management of chronic idiopathic orofacial pain: Trigeminal neuralgia, temporomandibular disorders and burning mouth syndrome. Medicina Fluminensis 2017;53:61–67.

20. Seada YI, Nofel R, Sayed HM. Comparison between trans-cranial electromagnetic stimulation and low-level laser on modulation of trigeminal neuralgia. J Phys Ther Sci 2013;25:911–914.

21. Aghamohammadi MDD, Amirnaseri RMD, Periovifar A, et al. Gasserian ganglion block with or without low-intensity laser therapy in trigeminal neuralgia: A comparative study. Neurosurgery Quarterly 2012;22:228–232.

22. Amoils S, Kues JR. The effect of low level laser therapy on acute headache syndromes. Laser Ther 1991;3:155–157.

23. Barbosa NG, Gonzaga AKG, de Sena Fernandes LL, et al. Evaluation of laser therapy and alphalipoic acid for the treatment of burning mouth syndrome: A randomized clinical trial. Lasers Med Sci 2018;33:1255–1262.

24. Arduino PG, Cafaro A, Garrone M, et al. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome. Lasers Med Sci 2016;31:811–816.

25. Valenzuela S, Lo´pez-Jornet P. Effects of low-level laser therapy on burning mouth syndrome. J Oral Rehabil 2017;44:125–132.

26. Arbabi-Kalati F, Bakhshani NM, Rasti M. Evaluation of the efficacy of low-level laser in improving the symptoms of burning mouth syndrome. J Clin Exp Dent 2015;7:e524–e527.

27. Spanemberg JC, López López J, de Figueiredo MA, Cherubini K, Salum FG. Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: A randomized, controlled trial. J Biomed Opt 2015;20:098001.

28. dos Santos Lde F, Carvalho Ade A, Leão JC, Cruz Perez DE, Castro JF. Effect of low-level laser therapy in the treatment of burning mouth syndrome: A case series. Photomed Laser Surg 2011;29:793–796.

29. dos Santos Lde F, de Andrade SC, Nogueira GE, Leão JC, de Freitas PM. Phototherapy on the treatment of burning mouth syndrome: A prospective analysis of 20 cases. Photochem Photobiol 2015;91:1231–1236.

30. Brailo V, Bosnjak A, Boras VV, Jurisic AK, Pelivan I, Kraljevic-Simunkovic S. Laser acupuncture in the treatment of burning mouth syndrome: A pilot study. Acupunct Med 2013;31: 453–454.

31. Pezelj-Ribaric´ S, Kqiku L, Brumini G, et al. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy. Lasers Med Sci 2013;28:297–301.

32. Brunner R, Haina D, Landthaler M, Waidelich W, Braun-Falco O. Applications of laser light of low power density. Experimental and clinical investigations. Curr Probl Dermatol 1986;15:111–116.

33. Coulthard P, Kushnerev E, Yates JM, et al. Interventions for iatrogenic inferior alveolar and lingual nerve injury. Cochrane Database Syst Rev 2014;(4):CD005293.

34. Fallah A, Mirzaei A, Gutknecht N, Demneh AS. Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy. Lasers Med Sci 2017;32:721–728.

35. Fan X, Wang S. A novel treatment of herpes zoster pain with pulsed laser irradiation. Dermatol Surg 2015;41:1189–1190.

36. Lorenz J, Kohlhoff H, Hansen HC, Kunze K, Bromm B. Abetafiber mediated activation of cingulate cortex as correlate of central post-stroke pain. Neuroreport 1998;9:659–663.

37. de Oliveira Martins D, Martinez dos Santos F, Evany de Oliveira M, de Britto LR, Benedito Dias Lemos J, Chacur M. Laser therapy and pain-related behavior after injury of the inferior alveolar nerve: Possible involvement of neurotrophins. J Neurotrauma 2013;30:480–486.

38. Chen YT, Wang HH, Wang TJ, Li YC, Chen TJ. Early application of low-level laser may reduce the incidence of postherpetic neu-ralgia (PHN). J Am Acad Dermatol 2016;75:572–577.

39. Ebrahimi H, Najafi S, Khayamzadeh M, Zahedi A, Mahdavi A. Therapeutic and analgesic efficacy of laser in conjunction with pharmaceutical therapy for trigeminal neuralgia. J Lasers Med Sci 2018;9:63–68.

40. Khullar SM, Emami B, Westermark A, Haanaes HR. Effect of low-level laser treatment on neurosensory deficits subsequent to sagittal split ramus osteotomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:132–138.

41. Khullar SM, Brodin P, Barkvoll P, Haanaes HR. Preliminary study of low-level laser for treatment of long-standing sensory aberrations in the inferior alveolar nerve. J Oral Maxillofac Surg 1996;54:2–7.

42. Eckerdal A, Bastian HL. Can low reactive-level laser therapy be used in the treatment of neurogenic facial pain? A double-blind, placebo controlled investigation of patients with trigeminal neuralgia. Laser Therapy 1996;8:247–251.

43. Sasaki K, Ohshiro T, Ohshiro T, Taniguchi Y. Low reactive level laser therapy in the treatment of post herpetic neuralgia. Laser Ther 2010;19:101–105.

44. Kato IT, Pellegrini VD, Prates RA, Ribeiro MS, Wetter NU, Sugaya NN. Low-level laser therapy in burning mouth syndrome patients: A pilot study. Photomed Laser Surg 2010;28:835–839.

45. Sugaya NN, Silva ÉF, Kato IT, Prates R, Gallo CB, Pellegrini VD. Low intensity laser therapy in patients with burning mouth syndrome: A randomized, placebo-controlled study. Braz Oral Res 2016;30:e108.

46. Romeo U, Del Vecchio A, Capocci M, Maggiore C, Ripari M. The low level laser therapy in the management of neurologicalburning mouth syndrome. A pilot study. Ann Stomatol (Roma) 2010;1:14–18.

47. Hong JN, Kim TH, Lim SD. Clinical trial of low reactive-level laser therapy in 20 patients with postherpetic neuralgia. Laser Ther 1990;2:167–170.

48. Midamba ED, Haanaes HR. Effect of low level laser therapy (LLLT) on inferior alveolar, mental and lingual nerves after traumatic injury in 15 patients. A pilot study. Laser Ther 1993;5:89–94.

49. Mizekami T, Yoshii N, Uhikubo Y, et al. Effect of diode laser for pain: A clinical study on different pain types. Laser Ther 1990;2:171–173.

50. Numazawa R, Kemmotsu O, Otsuka Het al. The role of laser therapy in intensive pain management of postherpetic neuralgia. Laser Ther 1996;8:143–148.

51. Otsuka H, Numazawa R, Okubo K, et al. Effects of helium-neon laser therapy on herpes zoster pain. Laser Ther 1995;7:27–32.

52. Shiroto C, Yodono M, Nakaji S. Pain attenuation with diode laser therapy: A retrospective study of the long-term LLLT experience in the private clinic environment. Laser Ther 1998;10:33–39.

53. Yang HW, Huang YF. Treatment of burning mouth syndrome with a low-level energy diode laser. Photomed Laser Surg 2011; 29:123–125.

54. Yang HW, Huang YF. Treatment of persistent idiopathic facial pain (PIFP) with a low-level energy diode laser. Photomed Laser Surg 2011;29:707–710.

55. Awad S, Hosam W. Low energy IPL therapy for the management of recalcitrant post-herpetic neuralgia. Laser Ther 2008; 17:23–28.

56. Bashiri H. Evaluation of low level laser therapy in reducing diabetic polyneuropathy related pain and sensorimotor disorders. Acta Med Iran 2013;51:543–547.

57. Matsumura C, Ishikawa F, Imai M, Kemmotsu O. Useful effect of application of heliumneon LLLT on an early stage case of herpes zoster: A case report. Laser Ther 1993;5:43–46.

58. Moore KC, Hira N, Kumar PS, Jayakumar CS, Ohshiro T. A double blind crossover trial of low level laser therapy in the treatment of postherpetic neuralgia. Laser Ther 2004;14:61–64.

59. Amanat D, Ebrahimi H, Lavaee F, Alipour A. The adjunct therapeutic effect of lasers with medication in the management of orofacial pain: Double blind randomized controlled trial. Photomed Laser Surg 2013;31:474–479.

60. Yamada H, Ogawa H. Comparative study of 60 mw diode laser therapy and 150 mw diode laser therapy in the treatment of pos-therpetic neuralgia. Laser Ther 1995;7:71–74.

61. Pinheiro AL, Cavalcanti ET, Pinheiro TI, Alves MJ, Manzi CT. Low-level laser therapy in the management of disorders of the maxillofacial region. J Clin Laser Med Surg 1997;15:181–183.

62. Kemmotsu O, Sato K, Furumido H, et al. Efficacy of low reactive-level laser therapy for pain attenuation of postherpetic neuralgia. Laser Ther 1991;3:71–75.

63. Iijima K, Shimoyama N, Shimoyama M, Yamamoto T, Shimizu T, Mizuguchi T. Effect of repeated irradiation of low-power He-Ne laser in pain relief from postherpetic neuralgia. Clin J Pain 1989;5:271–274.

64. Hansen HJ, Thorøe U. Low power laser biostimulation of chronic orofacial pain. A double-blind placebo controlled cross-over study in 40 patients. Pain 1990;43:169–179.

65. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9–19.